AU2003238678A1 - Novel crystalline forms of sumatriptan succinate - Google Patents

Novel crystalline forms of sumatriptan succinate

Info

Publication number
AU2003238678A1
AU2003238678A1 AU2003238678A AU2003238678A AU2003238678A1 AU 2003238678 A1 AU2003238678 A1 AU 2003238678A1 AU 2003238678 A AU2003238678 A AU 2003238678A AU 2003238678 A AU2003238678 A AU 2003238678A AU 2003238678 A1 AU2003238678 A1 AU 2003238678A1
Authority
AU
Australia
Prior art keywords
crystalline forms
novel crystalline
sumatriptan succinate
sumatriptan
succinate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003238678A
Inventor
Dasari Muralidhara Reddy
Bandi Parthasaradhi Reddy
Rapolu Raji Reddy
Kura Rathnakar Reddy
Kesireddy Subash Chander Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hetero Drugs Ltd
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Publication of AU2003238678A1 publication Critical patent/AU2003238678A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2003238678A 2003-05-08 2003-05-08 Novel crystalline forms of sumatriptan succinate Abandoned AU2003238678A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000180 WO2004099140A1 (en) 2003-05-08 2003-05-08 Novel crystalline forms of sumatriptan succinate

Publications (1)

Publication Number Publication Date
AU2003238678A1 true AU2003238678A1 (en) 2004-11-26

Family

ID=33428279

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003238678A Abandoned AU2003238678A1 (en) 2003-05-08 2003-05-08 Novel crystalline forms of sumatriptan succinate

Country Status (2)

Country Link
AU (1) AU2003238678A1 (en)
WO (1) WO2004099140A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009128089A2 (en) * 2008-02-11 2009-10-22 Matrix Laboratories Limited Novel solvate form of sumatriptan succinate and process for preparing sumatriptan salt employing the same
US9603937B2 (en) * 2015-03-09 2017-03-28 Theaprin Pharmaceuticals Inc. Platform drug delivery system utilizing crystal engineering and theanine dissolution

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
ES2033578B1 (en) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 PROCEDURE FOR OBTAINING 3- (2- (DIMETHYLAMINE) ETHYL) -N-METHYL-1H-INDOL-5-METHANOSULFONAMIDE.

Also Published As

Publication number Publication date
WO2004099140A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
AU2003202924A1 (en) Variation of neural-stimulation parameters
AU2003218758A1 (en) Derivatives of 1-phenyl-3-phenylpyrazole as herbicides
AU2003266346A1 (en) Stabillization of organic materials
AU2003279366A1 (en) Novel compounds
AU2003230192A1 (en) Novel crystalline forms of aripiprazole
AU2003255551A1 (en) Characterisation of paper
AU2003303648A1 (en) Novel 5-hydroxyindole-3-carboxylate derivatives
AU2003245027A1 (en) Novel crystalline forms of ziprasidone hydrochloride
AU2003222439A1 (en) Novel crystalline forms of tegaserod maleate
AU2003250858A1 (en) Use of organic compounds
AU2003280578A1 (en) Heterocyclic compounds
AU2003282162A1 (en) Novel adhesives comprising diacetals
AU2003217438A1 (en) Novel crystalline forms of levetiracetam
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives
AU2003238678A1 (en) Novel crystalline forms of sumatriptan succinate
AU2003228950A1 (en) Oocyte recording chamber
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003257541A1 (en) Novel crystals
AU2003217437A1 (en) Novel crystalline forms of lamotrigine
AU2003278422A1 (en) Amorphous form of losartan potassium
AU2003251259A1 (en) Novel compounds
AU2003238034A1 (en) Novel use of imidazotriazinones
AU2003238669A1 (en) Novel crystalline forms of parecoxib sodium
AU2003238668A1 (en) Novel crystalline forms of valdecoxib
AU2003264861A1 (en) Novel crystalline forms of celecoxib

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase